Navigation Links
InnovationRx, a Prescription Adherence Solutions Company, and InforMedix Partner to Market and Sell End-to-End Medication Adherence Solutions
Date:4/17/2008

ROCKVILLE, Md. and NEWTON, Mass., April 17 /PRNewswire-FirstCall/ -- InforMedix Holdings, Inc. (OTC Bulletin Board: IFMX), providing Med-ePhone(TM), Med-eMonitor(TM), and Med-eXpert(TM) Systems to improve medication adherence and health status monitoring, and InnovationRx, a provider of prescription medication adherence solutions, announced an agreement to market and sell a combined product line to a broad spectrum of Federal and State Governmental Agencies, insurance companies, health plans, managed care companies, disease management organizations, and other related private and public industry organizations and plans.

InnovationRx, the healthcare division of Innovation Group, employs an inter-disciplinary, multi-modal methodology to assess and improve medication adherence, which provides clinical evaluation, customized interventions and progress reports. Their services, developed in a research grant partnership with Northeastern University School of Pharmacy, are anchored by proprietary medication adherence risk-assessment instruments and intervention plans, combined with interactive Web-based tools and live pharmacists in call centers. These licensed pharmacists, trained in motivational interviewing and compliance, provide patients with personalized, one-to-one support and consultation. Innovation Group is a global company with revenues in excess of $250 million and is focused on providing risk management business solutions to various industries and marketplaces throughout the world.

The companies are collaborating to create discrete combinations of their respective products and services that address differing levels of adherence risk among low risk, medium risk, and high risk populations. Specifically combined product and service offerings will be developed, marketed and sold at specific price points. The combinations will be designed to provide the right mix of products and services to best achieve improved medication adherence, health outco
'/>"/>

SOURCE InforMedix Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Signalife Receives FDA Clearance for OTC Non-Prescription Event Recorder Device
2. Caliper Life Sciences Forms Alliance With Horizon Discovery to Provide Enhanced Solutions for Cancer Research Based on Isogenic Cell Lines
3. Compressus Completes Interoperability Implementation for E-Rad Solutions Teleradiology Customers
4. Abt Associates Clinical Trials Announces Name Change to Abt Bio-Pharma Solutions, Inc.
5. HighPoint Solutions Selected by Global Biotechnology Company to Provide Master Data Management Solution
6. Finesse Solutions Opens New E-Store for Sensors
7. Environmental Operating Solutions Completes Initial Tranche of $2.5 Million Institutional Financing
8. Immucor To Acquire BioArray Solutions Ltd.
9. The Bill & Melinda Gates Foundation, BIO, and Bio Ventures for Global Health Invite Proteome Systems CEO to Speak on TB Diagnostics Solutions At Partnering for Global Health Forum, Washington D.C.
10. Finesse Solutions, LLC Announces OPC Connectivity With Nova BioProfile 400
11. Hybrid materials: Exciting interdisciplinary field offering future solutions for industry

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...Nov.25/PRNewswire/-Cytochromatodayannouncedtheappo...ldtwillreplaceMr.UlrikSporkastheNovoA/Srepresentat...insunchangedatsixmembers. ,, "Weareverypleasedt...tingfromhisexperienceandguidanceasCytochromacontin...ialtypharmaceuticalcompany,"statedAlanLewis,PhD,Ch...
(Date:11/24/2009)....24/PRNewswire-FirstCall/--IES(Nasdaq: IESC ),alea...ystemsandservicesforthecommercial,industrialandres...inessgrouphasbeenawardedacontractfromManhattanTorc...afetylab(BSL-4)replacementfacilityattheU.S.ArmyMed...)atFortDetrickinFrederick,Md. ,, ThenewUSAMRIID...
(Date:11/24/2009)...celand,November24/PRNewswire-FirstCall/--deCODE,ge...eceivednoticefrom,theNasdaqStockMarketthattradingi...er30,2009andaForm25-NSEwillbefiledwiththe,Securiti...monstock,fromlistingonNasdaq,unlessthecompanyfiles...companyhasfiledsuchanappeal,which,willstaythesuspe...
(Date:11/24/2009)...lif.,Nov.24/PRNewswire-FirstCall/--NeurogesX,Inc.(...evelopingandcommercializingnovelpainmanagementther...dChiefExecutiveOfficer,isscheduledtopresentatthe21...ecember1-2,2009atTheNewYorkPalaceHotelinNewYork,Ne...nancialOfficer,willbeavailabletorespondtoquestions...
Breaking Biology Technology:Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3
...R, Mich., Feb. 18 NanoBio Corp., a,biopharmaceuti...ti-infective,treatments and intranasal vaccines, a... series B equity financing with Perseus LLC and ot...in funding has been directed toward the,developmen...m. , The series B funding will be used by the ...
...lif., Feb. 18 A new clinical study published this...ports that high-quality patient outcomes for breas...ity hospital setting. This is one of the few and t...arly relevant given that nearly two-thirds of all ...eated at community centers. , , The study tracked...
..., Feb. 18 Pharmos Corporation (Nasdaq: PARS ) a...nt with an Israel based company, Reperio Pharmaceu...ights and technical know how related to the compou...es. These CB2-selective cannabinoids are synthetic...al cannabinoids and thus display fewer of the unde...
Other Biology Technology:NanoBio Corporation Raises $12 Million in Series B Financing 2New Study Reports Improved Patient Outcomes for Breast Cancer Patients 2New Study Reports Improved Patient Outcomes for Breast Cancer Patients 3Pharmos Announces Agreement to Sell Certain CB2 Selective Agonists 2Pharmos Announces Agreement to Sell Certain CB2 Selective Agonists 3
(Date:11/23/2009)...INNATINew research presents strong evidence that t...both outdoor traffic-related pollution and indoor ...n one or the other exposure alone. , Environme...nati (UC) College of Medicine have shown that chil...d particles and indoor endotoxin during early life...
(Date:11/23/2009)...new study by the Wildlife Conservation Society say...swamp in the Republic of Congopart of the "mother ...t yearare becoming increasingly threatened by grow...ecommends protection of the swamp forests adjacent...ve after recent surveys confirmed that high densit...
(Date:11/23/2009)...ES, Iowa - The only swine vaccine available for th...rd infected with the virus. The vaccination marks ...rd diagnosed with the pandemic flu., Iowa State ...nce, developed the vaccine this summer and has bee...Iowa, Kansas and Illinois for several weeks., Th...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2DC 3A Muslim Coalition to Host Interfaith Hearing on Health Care 59326 1DC 3A Muslim Coalition to Host Interfaith Hearing on Health Care 59326 2Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 1Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 2Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 3Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 4Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 5Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 6Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 7Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 8Guardian Provides 100 25 Coverage For Swine Flu Vaccine 59321 1Guardian Provides 100 25 Coverage For Swine Flu Vaccine 59321 2
...ian islands of Borneo and Sumatra, scientists from... found what they say is the first demonstration in...ailable food supplies and brain size. , Based on t...ans confined to part of Borneo where food supplies...the process of natural selection comparatively sma...
...d most their contemporaries were not wiped out by ...paleontologist who says multiple meteor impacts, m...minated in the end of the Cretaceous Period. , Th...ser and earlier of a series of meteors and volcani...an 500,000 years, say Princeton University paleont...
...response to an avian influenza vaccine with doses ...a chemical mixture known as MF59. The research is ...ctious Diseases, now available online. , MF 59 i...ne system,s ability to respond to a stimulus. For ...H9N2 influenza vaccines--not the H5N1 virus curren...
Other Biology News:Study suggests evolutionary link between diet, brain size in orangutans 2Study suggests evolutionary link between diet, brain size in orangutans 3Study suggests evolutionary link between diet, brain size in orangutans 4'Fruit fly dating game' provides clues to our reproductive prowess 2'Fruit fly dating game' provides clues to our reproductive prowess 3
DHFR-1 FP-1 Forward Sequencing Primer from EPICENTRE Biotechnologies
Human Mesenchymal Stem Cell Functional Identification Kit from R&D Systems
Rabbit Anti-Syntrophin alpha 1 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Human HLA Class 1 A25 Monoclonal Antibody, Unconjugated, Clone 4i97 from Abcam
Biology Products: